Icahn School of Medicine at Mount Sinai, CNAG, Karolinska Institutet, and Stanford University will apply 3D spatial multi-omics across neuroscience, immunology, oncology, and tissue atlas research BOSTON — Stellaromics, Inc., the leader in 3D spatial multi-omics, today announced the first commercial placements of its Pyxa® platform, the industry’s first solution for true 3D spatial multi-omics […]
Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results. Integrated autoloader and BD FACSChorus™ Software speeds time to insight for new and experienced users. MILFORD, Mass. — Waters […]
Validated on the CellXpress.ai® Automated Cell Culture System, the new workflow combines organoid biology expertise and laboratory automation to help researchers reduce variability, expand scale, and move discoveries toward impact with greater confidence SAN JOSE, Calif. and VANCOUVER, BC – Molecular Devices, a Danaher company and a leading provider of high-performance life science solutions, and STEMCELL […]
10x Genomics, a leader in single-cell and spatial biology, to combine its spatial biology technologies with Lunit’s AI-powered H&E pathology analysis to advance oncology biomarker discovery SEOUL, South Korea — Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that 10x Genomics, Inc. (Nasdaq: TXG) will incorporate Lunit’s […]
Tenth SBIR award brings Partillion’s total non-dilutive federal funding to more than $8 million and supports development of Cell-Cell-seq workflows LOS ANGELES — Partillion Bioscience announced a two-year, $2.1 million NIH Small Business Innovation Research (SBIR) award from the National Institute of General Medical Sciences (NIGMS) to expand the company’s Cell-Cell-seq workflows. Partillion’s 10th SBIR […]
Submission marks the first time data from the AVA™ Emulation System will be evaluated as part of the FDA qualification process, reinforcing confidence in scalable human-relevant liver models BOSTON — Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, today announced it has submitted its FDA Innovative Science and Technology Approaches for New Drugs (ISTAND) […]
Microbubble-based technology enables magnetic bead-free cell selection for cell therapy research and development PRINCETON, N.J. — Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, today announced the expansion of its BubbleGen™ cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit. The kit, built on […]
Next-generation upgrade strengthens data comparability and compliance—without changing trusted instrumentation San Jose – Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, today announced the launch of Vi-CELL BLU 2.0 Viability Analyzer Software, a major upgrade that enables laboratories to modernize cell viability workflows while maintaining data continuity, […]
Acquisition adds regulated bioanalytical and CMC services, diagnostic reagents, and workflow critical products to support translational, clinical, and commercial development SHAKER HEIGHTS, Ohio — VION Biosciences (“VION”), a life sciences company building integrated capabilities across research, diagnostics, and drug development workflows, today announced the closing of its acquisition of Prolytix, a provider of regulated bioanalytical […]
Acquisition strengthens Revvity’s position in human-relevant life sciences tools for next-generation GLP-1 and GPCR-targeting therapies for metabolic drug discovery Combines HCD’s human pancreatic beta cell models with Revvity’s capabilities in cell analysis, detection, high-content screening and gene editing Expands Revvity’s ability to support customers across the research-to-clinic continuum, including emerging applications in clinical development and […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
